Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Atezolizumab 840 Mg / 14 Ml (60 Mg/ml) (CDM 4070075) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 27, 2026 , from http://ppman.hank.ai/transparency/procedure/4070075/by-state?code_type=CDM
“Atezolizumab 840 Mg / 14 Ml (60 Mg/ml) (CDM 4070075) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4070075/by-state?code_type=CDM. Accessed
October 27, 2026 .
“Atezolizumab 840 Mg / 14 Ml (60 Mg/ml) (CDM 4070075) by State,” HANK Price Transparency ,
accessed October 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/4070075/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4070075 — Atezolizumab 840 Mg / 14 Ml (60 Mg/ml)
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$15,177
National median
$7,040 – $18,343
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4070075 (CDM), with interquartile range
State Median p25 p75
VT $15,177 $7,040 $18,343